Free Trial

Symbotic (SYM) Financials

Symbotic logo
$35.70 +4.54 (+14.57%)
Closing price 06/18/2025 04:00 PM Eastern
Extended Trading
$35.57 -0.13 (-0.37%)
As of 06/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Symbotic

Annual Income Statements for Symbotic

This table shows Symbotic's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024
Net Income / (Loss) Attributable to Common Shareholders
-110 0.00 -6.86 -24 -13
Consolidated Net Income / (Loss)
-110 -122 -139 -208 -85
Net Income / (Loss) Continuing Operations
-110 -122 -139 -208 -85
Total Pre-Tax Income
-110 -122 -139 -213 -80
Total Operating Income
-110 -122 -140 -223 -117
Total Gross Profit
-19 10 100 190 246
Total Revenue
92 252 593 1,177 1,788
Operating Revenue
92 252 593 1,177 1,788
Total Cost of Revenue
111 241 494 987 1,543
Operating Cost of Revenue
111 241 494 987 1,543
Total Operating Expenses
91 133 240 413 362
Selling, General & Admin Expense
36 59 116 218 189
Research & Development Expense
56 73 124 195 173
Total Other Income / (Expense), net
0.81 0.07 1.29 11 37
Other Income / (Expense), net
0.81 0.07 1.29 11 37
Income Tax Expense
-0.05 0.00 0.00 -4.62 4.21
Other Gains / (Losses), net
- - 0.00 0.00 -0.78
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 0.00 -60 -184 -71
Basic Earnings per Share
$0.00 $0.00 ($0.13) ($0.37) ($0.14)
Weighted Average Basic Shares Outstanding
0.00 0.00 54.09M 64.34M 95.70M
Diluted Earnings per Share
$0.00 $0.00 ($0.13) ($0.37) ($0.14)
Weighted Average Diluted Shares Outstanding
0.00 0.00 54.09M 64.34M 95.70M
Weighted Average Basic & Diluted Shares Outstanding
- 0.00 553.91M 557.24M 587.42M

Quarterly Income Statements for Symbotic

This table shows Symbotic's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 9/24/2022 12/24/2022 3/25/2023 6/24/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025
Net Income / (Loss) Attributable to Common Shareholders
67 -7.19 -6.12 -4.35 -6.21 -2.84 -8.81 -4.68 2.84 -3.48 -3.93
Consolidated Net Income / (Loss)
-52 -68 -55 -39 -45 -19 -55 -27 16 -19 -21
Net Income / (Loss) Continuing Operations
-53 -68 -55 -39 -45 -19 -55 -27 16 -19 -21
Total Pre-Tax Income
-53 -68 -55 -39 -50 -19 -55 -26 20 -17 -20
Total Operating Income
-54 -70 -58 -42 -54 -25 -65 -38 11 -25 -32
Total Gross Profit
37 35 43 53 59 64 30 55 96 80 108
Total Revenue
244 206 267 312 392 360 393 470 565 487 550
Operating Revenue
244 206 267 312 392 360 393 470 565 487 550
Total Cost of Revenue
208 171 224 259 333 296 363 415 468 407 442
Operating Cost of Revenue
208 171 224 259 333 296 363 415 468 407 442
Total Operating Expenses
91 105 101 95 113 89 95 93 86 105 140
Selling, General & Admin Expense
48 54 51 46 67 47 49 48 45 61 78
Research & Development Expense
43 51 50 49 46 42 46 45 40 44 62
Total Other Income / (Expense), net
1.05 1.83 2.28 2.94 3.66 6.20 9.81 12 9.42 7.82 12
Other Income / (Expense), net
1.05 1.83 2.28 2.94 3.66 6.20 9.81 12 9.42 7.82 12
Income Tax Expense
- 0.25 -0.02 0.01 -4.86 0.17 -0.25 0.18 4.11 0.15 -1.40
Other Gains / (Losses), net
- - - 0.00 - 0.00 - -0.54 - -1.56 -2.49
Net Income / (Loss) Attributable to Noncontrolling Interest
-48 -61 -49 -35 -39 -16 -46 -22 13 -15 -18
Basic Earnings per Share
($0.10) ($0.12) ($0.10) ($0.07) ($0.08) ($0.03) ($0.09) ($0.05) $0.03 ($0.03) ($0.04)
Weighted Average Basic Shares Outstanding
54.09M 58.24M 60.50M 61.78M 64.34M 83.32M 93.04M 102.41M 95.70M 106.10M 107.73M
Diluted Earnings per Share
($0.10) ($0.12) ($0.10) ($0.07) ($0.08) ($0.03) ($0.09) ($0.05) $0.03 ($0.03) ($0.04)
Weighted Average Diluted Shares Outstanding
54.09M 58.24M 60.50M 61.78M 64.34M 83.32M 93.04M 102.41M 95.70M 106.10M 107.73M
Weighted Average Basic & Diluted Shares Outstanding
553.91M 555.52M 555.46M 555.85M 557.24M 577.06M 584.63M 585.58M 587.42M 588.39M 589.61M

Annual Cash Flow Statements for Symbotic

This table details how cash moves in and out of Symbotic's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024
Net Change in Cash & Equivalents
-30 98 197 -93 469
Net Cash From Operating Activities
-124 110 -148 231 -58
Net Cash From Continuing Operating Activities
-124 110 -148 231 -58
Net Income / (Loss) Continuing Operations
-110 -122 -139 -208 -85
Consolidated Net Income / (Loss)
-110 -122 -139 -208 -85
Depreciation Expense
5.73 4.49 5.99 11 23
Non-Cash Adjustments To Reconcile Net Income
0.11 0.15 32 179 136
Changes in Operating Assets and Liabilities, net
-21 227 -47 248 -133
Net Cash From Investing Activities
-5.06 -12 -18 -299 156
Net Cash From Continuing Investing Activities
-5.07 -12 -18 -299 156
Purchase of Property, Plant & Equipment
-5.07 -12 -18 -21 -44
Acquisitions
- - 0.00 0.00 -90
Purchase of Investments
- 0.00 0.00 -408 -49
Sale of Property, Plant & Equipment
- 0.00 0.00 0.07 0.00
Sale and/or Maturity of Investments
- 0.00 0.00 130 340
Net Cash From Financing Activities
100 0.00 362 -24 371
Net Cash From Continuing Financing Activities
100 0.00 362 -24 371
Payment of Dividends
0.00 0.00 -300 0.00 -48
Issuance of Common Equity
0.00 0.00 0.00 2.57 264
Other Financing Activities, net
0.00 0.00 662 -27 156
Effect of Exchange Rate Changes
-0.68 0.97 0.57 0.23 -0.00

Quarterly Cash Flow Statements for Symbotic

This table details how cash moves in and out of Symbotic's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 9/24/2022 12/24/2022 3/25/2023 6/24/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025
Net Change in Cash & Equivalents
-58 -2.73 -92 -1.46 3.29 227 416 -31 -143 176 52
Net Cash From Operating Activities
-52 101 31 54 45 -30 21 50 -99 205 270
Net Cash From Continuing Operating Activities
-52 101 31 54 45 -30 21 50 -99 205 270
Net Income / (Loss) Continuing Operations
-53 -68 -55 -39 -45 -19 -55 -47 16 -19 -21
Consolidated Net Income / (Loss)
-53 -68 -55 -39 -45 -19 -55 -47 16 -19 -21
Depreciation Expense
1.79 2.08 2.07 2.46 4.71 3.20 3.16 11 6.43 7.65 12
Non-Cash Adjustments To Reconcile Net Income
28 50 41 37 51 30 53 28 25 28 43
Changes in Operating Assets and Liabilities, net
-28 117 43 53 34 -44 19 59 -147 188 235
Net Cash From Investing Activities
-7.18 -104 -112 -55 -28 99 137 -34 -45 -25 -221
Net Cash From Continuing Investing Activities
-7.18 -104 -112 -55 -28 99 137 -34 -45 -25 -221
Purchase of Property, Plant & Equipment
-7.18 -6.99 -6.02 -7.36 -0.96 -2.99 -2.87 -17 -21 -7.36 -21
Acquisitions
- - - - - 0.00 - - -24 -18 -200
Net Cash From Financing Activities
- 0.00 -11 - -13 159 258 -48 1.75 -3.86 2.85
Net Cash From Continuing Financing Activities
- 0.00 -11 - -13 159 258 -48 1.75 -3.86 2.85
Payment of Dividends
- - - - - 0.00 - - -0.56 -0.85 -0.38
Effect of Exchange Rate Changes
0.49 0.02 - -0.05 0.14 -0.00 -0.01 -0.01 0.02 -0.08 0.05

Annual Balance Sheets for Symbotic

This table presents Symbotic's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024
Total Assets
0.13 281 631 1,051 1,579
Total Current Assets
0.01 260 605 992 1,356
Cash & Equivalents
0.00 157 353 259 727
Accounts Receivable
- 63 105 190 420
Inventories, net
- 34 92 136 106
Prepaid Expenses
0.01 6.37 26 85 101
Other Current Assets
- 0.49 29 35 1.06
Plant, Property, & Equipment, net
0.00 19 25 35 97
Total Noncurrent Assets
0.13 1.50 0.99 24 126
Long-Term Investments
- - - 0.00 81
Intangible Assets
- 1.16 0.65 0.22 3.66
Other Noncurrent Operating Assets
0.13 0.33 0.34 24 41
Total Liabilities & Shareholders' Equity
0.13 281 631 1,051 1,579
Total Liabilities
0.13 558 562 1,053 1,188
Total Current Liabilities
0.13 337 523 1,025 1,017
Accounts Payable
0.01 28 68 110 175
Accrued Expenses
0.10 31 47 128 166
Current Deferred Revenue
- 259 394 787 676
Total Noncurrent Liabilities
0.00 221 39 28 171
Noncurrent Deferred Revenue
- 217 31 0.00 129
Other Noncurrent Operating Liabilities
0.00 3.99 7.90 28 42
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
0.01 -1,113 69 -2.72 390
Total Preferred & Common Equity
0.01 0.00 7.18 0.08 197
Total Common Equity
0.01 -1,113 7.18 0.08 197
Common Stock
0.03 17 1,238 1,254 1,524
Retained Earnings
-0.02 -1,155 -1,287 -1,310 -1,324
Accumulated Other Comprehensive Income / (Loss)
- -2.09 -2.29 -1.69 -2.59
Noncontrolling Interest
- 0.00 62 -2.80 193

Quarterly Balance Sheets for Symbotic

This table presents Symbotic's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025
Period end date 6/25/2022 12/24/2022 3/25/2023 6/24/2023 12/30/2023 3/30/2024 6/29/2024 12/28/2024 3/29/2025
Total Assets
613 809 910 970 1,316 1,553 1,500 1,716 1,964
Total Current Assets
591 772 866 922 1,251 1,449 1,313 1,458 1,498
Cash & Equivalents
412 351 257 255 486 901 870 903 955
Accounts Receivable
2.55 146 188 165 293 267 203 358 298
Inventories, net
127 111 140 167 138 120 132 109 146
Prepaid Expenses
49 32 39 36 104 110 101 86 94
Other Current Assets
0.55 35 37 42 42 1.17 6.75 3.22 4.98
Plant, Property, & Equipment, net
21 30 36 41 35 75 81 105 124
Total Noncurrent Assets
1.14 6.60 7.59 7.17 30 29 106 152 342
Long-Term Investments
- - - - - - - 86 85
Goodwill
- - - - - - - - 69
Intangible Assets
0.80 0.54 0.43 0.34 0.00 0.00 0.00 15 126
Other Noncurrent Operating Assets
0.34 6.06 7.16 6.83 30 29 106 51 63
Total Liabilities & Shareholders' Equity
613 809 910 970 1,316 1,553 1,500 1,716 1,964
Total Liabilities
540 759 888 948 1,150 1,159 1,154 1,322 1,543
Total Current Liabilities
445 736 850 898 1,096 1,076 1,023 1,197 1,473
Accounts Payable
97 61 88 74 103 133 128 206 220
Accrued Expenses
51 73 71 61 116 119 177 203 166
Current Deferred Revenue
290 580 665 742 840 815 718 787 1,086
Total Noncurrent Liabilities
95 23 38 50 54 83 131 125 70
Noncurrent Deferred Revenue
89 9.34 24 33 17 45 82 77 8.15
Other Noncurrent Operating Liabilities
5.98 13 15 17 37 39 49 48 62
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
73 50 21 22 166 394 347 394 422
Total Preferred & Common Equity
7.01 5.32 2.37 2.48 -57 197 197 197 205
Total Common Equity
0.00 5.32 2.37 2.48 -57 197 197 197 205
Common Stock
1,232 1,243 1,246 1,250 1,258 1,522 1,526 1,527 1,539
Retained Earnings
-1,281 -1,294 -1,300 -1,304 -1,313 -1,322 -1,327 -1,327 -1,331
Accumulated Other Comprehensive Income / (Loss)
-2.14 -2.31 -2.09 -1.83 -1.77 -2.37 -2.63 -2.70 -2.70
Noncontrolling Interest
66 45 19 19 223 197 150 197 216

Annual Metrics And Ratios for Symbotic

This table displays calculated financial ratios and metrics derived from Symbotic's official financial filings.

Metric 2020 2021 2022 2023 2024
Period end date 9/26/2020 9/25/2021 9/24/2022 9/30/2023 9/28/2024
Growth Metrics
- - - - -
Revenue Growth
0.00% 173.56% 135.52% 98.36% 51.94%
EBITDA Growth
0.00% -13.47% -12.97% -51.17% 72.07%
EBIT Growth
0.00% -11.63% -13.71% -52.79% 62.50%
NOPAT Growth
0.00% -10.88% -14.70% -59.02% 47.71%
Net Income Growth
0.00% -11.68% -13.71% -49.47% 59.27%
EPS Growth
0.00% 0.00% 0.00% -184.62% 62.16%
Operating Cash Flow Growth
0.00% 188.14% -235.30% 255.68% -125.16%
Free Cash Flow Firm Growth
0.00% 0.00% -171.09% 143.44% -296.81%
Invested Capital Growth
0.00% -1,814,030.72% 34.38% -92.69% 23.67%
Revenue Q/Q Growth
0.00% 0.00% 26.42% 14.33% 8.05%
EBITDA Q/Q Growth
0.00% 0.00% 17.77% 2.85% 48.21%
EBIT Q/Q Growth
0.00% 0.00% 16.88% 1.38% 38.83%
NOPAT Q/Q Growth
0.00% 0.00% 16.26% 0.17% 27.75%
Net Income Q/Q Growth
0.00% 0.00% 17.53% 3.04% 32.83%
EPS Q/Q Growth
0.00% 0.00% -218.18% 5.13% 36.36%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -78.21% 71.28% -167.66%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 1,957.58% -168.75%
Invested Capital Q/Q Growth
0.00% 0.00% 15.96% -12.05% 20.09%
Profitability Metrics
- - - - -
Gross Margin
-20.56% 4.15% 16.80% 16.12% 13.74%
EBITDA Margin
-112.76% -46.77% -22.43% -17.10% -3.14%
Operating Margin
-119.86% -48.58% -23.66% -18.97% -6.53%
EBIT Margin
-118.98% -48.55% -23.44% -18.06% -4.46%
Profit (Net Income) Margin
-118.93% -48.55% -23.44% -17.66% -4.74%
Tax Burden Percent
99.96% 100.00% 100.00% 97.83% 106.26%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-323,225.82% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-504,955.96% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-1,456,445.94% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-1,779,671.76% 88.33% 133.72% -627.85% -43.71%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-82,441.46% -87.16% -30.51% -25.27% -6.06%
Return on Assets (ROA)
-82,406.10% -87.16% -30.51% -24.72% -6.44%
Return on Common Equity (ROCE)
-1,779,671.76% 355.02% 710.97% -68.89% -22.26%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% -1,936.09% 0.00% -42.93%
Net Operating Profit after Tax (NOPAT)
-77 -86 -98 -156 -82
NOPAT Margin
-83.90% -34.01% -16.56% -13.28% -4.57%
Net Nonoperating Expense Percent (NNEP)
181,730.14% -46.80% -16.01% -11.49% -0.44%
Cost of Revenue to Revenue
120.56% 95.85% 83.21% 83.88% 86.26%
SG&A Expenses to Revenue
38.64% 23.60% 19.53% 18.52% 10.57%
R&D to Revenue
60.66% 29.13% 20.92% 16.57% 9.70%
Operating Expenses to Revenue
99.31% 52.73% 40.45% 35.09% 20.27%
Earnings before Interest and Taxes (EBIT)
-110 -122 -139 -213 -80
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-104 -118 -133 -201 -56
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
45,498.86 0.00 809.95 226,609.56 75.77
Price to Tangible Book Value (P/TBV)
45,498.86 0.00 890.52 0.00 77.20
Price to Revenue (P/Rev)
3.04 1.60 9.81 15.79 8.36
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
11,714.26 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
3.04 4.29 9.32 15.32 8.01
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 9.87 0.00 78.14 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 3.11 0.00 167.84 0.00
Leverage & Solvency
- - - - -
Debt to Equity
2.88 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00
Financial Leverage
2.88 0.57 2.45 -13.57 -3.50
Leverage Ratio
21.60 -1.01 -4.38 25.40 6.79
Compound Leverage Factor
21.60 -1.01 -4.38 25.40 6.79
Debt to Total Capital
74.26% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
74.26% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% -301.93% 89.58% 103.02% 49.44%
Common Equity to Total Capital
25.74% 401.93% 10.42% -3.02% 50.56%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00
Altman Z-Score
-703.54 -6.20 3.72 9.25 7.59
Noncontrolling Interest Sharing Ratio
0.00% -301.94% -431.68% 89.03% 49.07%
Liquidity Ratios
- - - - -
Current Ratio
0.05 0.77 1.16 0.97 1.33
Quick Ratio
0.00 0.65 0.88 0.72 1.13
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 348 -247 107 -211
Operating Cash Flow to CapEx
-2,451.33% 900.45% -825.89% 1,085.83% -130.88%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - -
Asset Turnover
692.88 1.80 1.30 1.40 1.36
Accounts Receivable Turnover
0.00 0.00 7.04 7.96 5.86
Inventory Turnover
0.00 0.00 7.87 8.66 12.73
Fixed Asset Turnover
0.00 0.00 27.28 39.64 27.17
Accounts Payable Turnover
12,335.11 17.23 10.24 11.07 10.82
Days Sales Outstanding (DSO)
0.00 0.00 51.86 45.84 62.27
Days Inventory Outstanding (DIO)
0.00 0.00 46.38 42.16 28.66
Days Payable Outstanding (DPO)
0.03 21.18 35.66 32.98 33.73
Cash Conversion Cycle (CCC)
-0.03 -21.18 62.58 55.02 57.20
Capital & Investment Metrics
- - - - -
Invested Capital
0.02 -434 -285 -548 -418
Invested Capital Turnover
3,852.33 -1.16 -1.65 -2.83 -3.70
Increase / (Decrease) in Invested Capital
0.00 -434 149 -264 130
Enterprise Value (EV)
280 1,082 5,527 18,034 14,328
Market Capitalization
280 402 5,819 18,582 14,944
Book Value per Share
$0.00 ($27.13) $0.01 $0.00 $0.34
Tangible Book Value per Share
$0.00 ($27.15) $0.01 $0.00 $0.33
Total Capital
0.02 -277 69 -2.72 390
Total Debt
0.02 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00
Net Debt
0.02 -157 -353 -546 -809
Capital Expenditures (CapEx)
5.07 12 18 21 44
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.10 -233 -271 -579 -389
Debt-free Net Working Capital (DFNWC)
-0.10 -77 82 -34 338
Net Working Capital (NWC)
-0.12 -77 82 -34 338
Net Nonoperating Expense (NNE)
32 37 41 52 2.96
Net Nonoperating Obligations (NNO)
0.02 -157 -353 -546 -809
Total Depreciation and Amortization (D&A)
5.73 4.49 5.99 11 23
Debt-free, Cash-free Net Working Capital to Revenue
-0.11% -92.57% -45.68% -49.21% -21.75%
Debt-free Net Working Capital to Revenue
-0.11% -30.39% 13.90% -2.86% 18.92%
Net Working Capital to Revenue
-0.13% -30.39% 13.90% -2.86% 18.92%
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 ($0.38) ($0.13) ($0.37) ($0.14)
Adjusted Weighted Average Basic Shares Outstanding
0.00 41.40M 54.09M 64.34M 95.70M
Adjusted Diluted Earnings per Share
$0.00 ($0.38) ($0.13) ($0.37) ($0.14)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 41.40M 54.09M 64.34M 95.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($0.38) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 34.61M 553.91M 557.24M 587.42M
Normalized Net Operating Profit after Tax (NOPAT)
-77 -86 -98 -156 -82
Normalized NOPAT Margin
-83.90% -34.01% -16.56% -13.28% -4.57%
Pre Tax Income Margin
-118.98% -48.55% -23.44% -18.06% -4.46%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - -
Dividend Payout Ratio
0.00% 0.00% -215.69% 0.00% -56.94%
Augmented Payout Ratio
0.00% 0.00% -215.69% 0.00% -56.94%

Quarterly Metrics And Ratios for Symbotic

This table displays calculated financial ratios and metrics derived from Symbotic's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 9/24/2022 12/24/2022 3/25/2023 6/24/2023 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
102.96% 167.72% 177.15% 77.63% 60.34% 74.47% 47.40% 50.83% 44.06% 35.21% 39.74%
EBITDA Growth
35.84% -202.64% -87.33% -16.42% 11.46% 76.08% 2.69% 58.19% 158.67% 41.66% 84.47%
EBIT Growth
34.66% -193.82% -85.38% -18.85% 5.60% 72.10% 0.63% 33.44% 140.39% 11.08% 63.06%
NOPAT Growth
33.41% -201.49% -92.64% -27.18% 0.69% 63.92% -12.43% 10.45% 123.00% 1.87% 50.60%
Net Income Growth
36.27% -194.91% -85.32% -14.30% 12.57% 71.95% 1.06% 31.61% 135.13% 2.89% 60.90%
EPS Growth
-171.43% 0.00% 0.00% -133.33% 20.00% 75.00% 10.00% 28.57% 137.50% 0.00% 55.56%
Operating Cash Flow Growth
-480.40% 152.63% 130.43% 259.35% 186.43% -129.84% -32.70% -6.53% -323.19% 780.02% 1,179.30%
Free Cash Flow Firm Growth
0.00% 9,936.94% 39.97% 202.66% 220.76% -85.46% -82.21% -93.35% -153.58% -27.31% -45.94%
Invested Capital Growth
34.38% -232.02% 0.00% -44.53% -92.69% -28.19% -26.46% -7.03% 23.67% -16.86% -10.93%
Revenue Q/Q Growth
39.22% -15.59% 29.34% 16.86% 25.67% -8.15% 9.28% 10.85% 20.03% -13.79% 12.94%
EBITDA Q/Q Growth
-63.66% -27.57% 18.72% 31.39% -24.46% 65.54% -230.68% 59.70% 274.64% -134.26% 11.95%
EBIT Q/Q Growth
-62.00% -27.18% 18.16% 29.51% -28.67% 62.41% -191.44% 36.79% 178.08% -182.77% -21.06%
NOPAT Q/Q Growth
-64.42% -28.10% 17.04% 27.22% -28.39% 53.46% -158.55% 26.17% 132.98% -298.53% -30.17%
Net Income Q/Q Growth
-51.93% -30.88% 18.49% 29.48% -16.22% 58.01% -187.49% 34.74% 159.70% -216.08% -15.76%
EPS Q/Q Growth
-233.33% -20.00% 16.67% 30.00% -14.29% 62.50% -200.00% 28.57% 160.00% -200.00% -33.33%
Operating Cash Flow Q/Q Growth
-52.30% 296.15% -69.01% 72.14% -17.39% -167.71% 169.89% 139.10% -297.25% 306.30% 31.48%
Free Cash Flow Firm Q/Q Growth
-58.31% 447.08% -38.31% -69.71% 86.23% -58.22% -24.49% -86.78% -1,600.05% 156.68% -43.84%
Invested Capital Q/Q Growth
15.96% -39.61% -11.02% -10.94% -12.05% 7.12% -9.53% 2.61% 20.09% -42.20% -3.97%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
15.03% 17.06% 16.06% 16.97% 15.00% 17.80% 7.68% 11.69% 17.08% 16.45% 19.62%
EBITDA Margin
-21.06% -31.82% -20.00% -11.74% -11.63% -4.36% -13.20% -3.25% 4.74% -1.88% -1.47%
Operating Margin
-22.22% -33.72% -21.63% -13.47% -13.76% -6.97% -16.50% -8.00% 1.93% -5.06% -5.83%
EBIT Margin
-21.79% -32.83% -20.77% -12.53% -12.83% -5.25% -14.00% -5.53% 3.60% -3.45% -3.70%
Profit (Net Income) Margin
-21.25% -32.95% -20.77% -12.53% -11.59% -5.30% -13.94% -5.68% 2.83% -3.81% -3.90%
Tax Burden Percent
97.53% 100.37% 99.97% 100.01% 90.34% 100.91% 99.54% 102.76% 78.58% 110.20% 105.37%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 20.24% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
133.72% -103.83% -977.26% -452.56% -627.85% -147.15% -76.32% -68.43% -43.71% -30.06% -12.45%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-28.36% -41.88% -20.40% -16.30% -17.95% -6.58% -16.57% -7.41% 4.89% -4.36% -4.36%
Return on Assets (ROA)
-27.66% -42.03% -20.39% -16.30% -16.22% -6.64% -16.50% -7.61% 3.84% -4.81% -4.59%
Return on Common Equity (ROCE)
710.97% 3.08% -107.93% -11.83% -68.89% 35.28% -36.67% -36.96% -22.26% -7.49% -6.14%
Return on Equity Simple (ROE_SIMPLE)
0.00% -3,457.11% 0.00% 0.00% 0.00% 278.28% -80.36% -64.14% 0.00% -42.80% -24.70%
Net Operating Profit after Tax (NOPAT)
-38 -49 -40 -29 -38 -18 -45 -26 8.68 -17 -22
NOPAT Margin
-15.55% -23.60% -15.14% -9.43% -9.63% -4.88% -11.55% -5.60% 1.54% -3.54% -4.08%
Net Nonoperating Expense Percent (NNEP)
-5.46% -8.56% -6.49% -2.10% -1.70% -0.27% -1.33% -0.06% 1.07% -0.15% 0.10%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - -10.60% - - - -4.38% -5.32%
Cost of Revenue to Revenue
84.97% 82.94% 83.94% 83.03% 85.00% 82.20% 92.32% 88.31% 82.92% 83.55% 80.38%
SG&A Expenses to Revenue
19.47% 26.19% 19.07% 14.77% 17.08% 13.06% 12.37% 10.18% 8.04% 12.55% 14.25%
R&D to Revenue
17.78% 24.59% 18.61% 15.66% 11.68% 11.71% 11.81% 9.51% 7.11% 8.96% 11.20%
Operating Expenses to Revenue
37.25% 50.78% 37.69% 30.44% 28.76% 24.77% 24.18% 19.69% 15.15% 21.51% 25.45%
Earnings before Interest and Taxes (EBIT)
-53 -68 -55 -39 -50 -19 -55 -26 20 -17 -20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-51 -66 -53 -37 -46 -16 -52 -15 27 -9.16 -8.07
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
809.95 1,146.73 5,086.00 8,863.57 226,609.56 0.00 131.75 104.59 75.77 71.97 57.75
Price to Tangible Book Value (P/TBV)
890.52 1,276.20 6,204.87 10,250.45 0.00 0.00 131.75 104.59 77.20 77.90 1,083.09
Price to Revenue (P/Rev)
9.81 8.45 13.48 21.32 15.79 21.44 17.82 12.42 8.36 7.39 5.73
Price to Earnings (P/E)
0.00 678.45 367.39 448.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.15% 0.27% 0.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
9.32 7.89 12.99 20.84 15.32 21.10 17.30 11.99 8.01 6.97 5.33
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 246.71 159.22 78.14 281.95 282.17 231.09 0.00 75.40 25.93
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 10.05 39.90 0.00 167.84 0.00 0.00 0.00 0.00 2,978.36 4,274.93
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
2.45 -1.27 -21.57 -9.74 -13.57 -5.20 -3.41 -3.75 -3.50 -2.97 -2.44
Leverage Ratio
-4.38 3.20 42.42 16.70 25.40 9.83 5.93 6.70 6.79 5.42 4.31
Compound Leverage Factor
-4.38 3.20 42.42 16.70 25.40 9.83 5.93 6.70 6.79 5.42 4.31
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
89.58% 89.42% 88.96% 88.55% 103.02% 134.46% 49.93% 43.33% 49.44% 50.11% 51.27%
Common Equity to Total Capital
10.42% 10.58% 11.04% 11.45% -3.02% -34.46% 50.07% 56.67% 50.56% 49.89% 48.73%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
4.17 3.26 6.94 12.96 9.76 14.59 13.36 10.73 7.80 6.60 4.70
Noncontrolling Interest Sharing Ratio
-431.68% 102.97% 88.96% 97.39% 89.03% 123.98% 51.95% 45.98% 49.07% 75.09% 50.63%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.16 1.05 1.02 1.03 0.97 1.14 1.35 1.28 1.33 1.22 1.02
Quick Ratio
0.88 0.81 0.77 0.75 0.72 0.88 1.13 1.05 1.13 1.05 0.85
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-187 649 401 121 226 94 71 8.07 -121 69 39
Operating Cash Flow to CapEx
-717.42% 1,445.67% 520.39% 732.76% 4,623.88% -1,007.35% 733.96% 293.90% -465.12% 2,786.83% 1,311.16%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.30 1.28 0.98 1.30 1.40 1.25 1.18 1.34 1.36 1.26 1.18
Accounts Receivable Turnover
7.04 0.00 4.75 12.26 7.96 6.07 6.41 8.98 5.86 5.89 7.34
Inventory Turnover
7.87 0.00 5.32 5.86 8.66 8.95 9.62 9.55 12.73 13.42 13.02
Fixed Asset Turnover
27.28 0.00 25.13 33.52 39.64 40.79 26.35 27.14 27.17 27.34 20.84
Accounts Payable Turnover
10.24 19.40 8.47 10.06 11.07 13.60 11.30 14.12 10.82 10.70 9.81
Days Sales Outstanding (DSO)
51.86 0.00 76.84 29.77 45.84 60.17 56.94 40.64 62.27 61.97 49.73
Days Inventory Outstanding (DIO)
46.38 0.00 68.64 62.23 42.16 40.80 37.96 38.24 28.66 27.19 28.03
Days Payable Outstanding (DPO)
35.66 18.82 43.08 36.29 32.98 26.84 32.29 25.86 33.73 34.11 37.22
Cash Conversion Cycle (CCC)
62.58 -18.82 102.40 55.71 55.02 74.13 62.61 53.02 57.20 55.06 40.54
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-285 -397 -441 -489 -548 -509 -558 -524 -418 -595 -619
Invested Capital Turnover
-1.65 -15.00 -4.05 -2.49 -2.83 -2.94 -2.92 -3.27 -3.70 -3.47 -3.52
Increase / (Decrease) in Invested Capital
149 -698 -441 -151 -264 -112 -117 -34 130 -86 -61
Enterprise Value (EV)
5,527 5,702 11,600 21,454 18,034 28,080 25,213 19,835 14,328 13,353 11,038
Market Capitalization
5,819 6,104 12,044 21,946 18,582 28,532 25,968 20,556 14,944 14,145 11,862
Book Value per Share
$0.01 $0.01 $0.00 $0.00 $0.00 ($0.69) $0.34 $0.34 $0.34 $0.33 $0.35
Tangible Book Value per Share
$0.01 $0.01 $0.00 $0.00 $0.00 ($0.69) $0.34 $0.34 $0.33 $0.31 $0.02
Total Capital
69 50 21 22 -2.72 166 394 347 390 394 422
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-353 -448 -462 -511 -546 -675 -951 -870 -809 -989 -1,040
Capital Expenditures (CapEx)
7.18 6.99 6.02 7.36 0.96 2.99 2.87 17 21 7.36 21
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-271 -411 -446 -487 -579 -520 -578 -580 -389 -641 -930
Debt-free Net Working Capital (DFNWC)
82 36 17 24 -34 155 373 291 338 262 25
Net Working Capital (NWC)
82 36 17 24 -34 155 373 291 338 262 25
Net Nonoperating Expense (NNE)
14 19 15 9.67 7.66 1.50 9.40 0.39 -7.27 1.28 -1.00
Net Nonoperating Obligations (NNO)
-353 -448 -462 -511 -546 -675 -951 -870 -809 -989 -1,040
Total Depreciation and Amortization (D&A)
1.79 2.08 2.07 2.46 4.71 3.20 3.16 11 6.43 7.65 12
Debt-free, Cash-free Net Working Capital to Revenue
-45.68% -56.92% -49.92% -47.33% -49.21% -39.07% -39.70% -35.03% -21.75% -33.50% -44.88%
Debt-free Net Working Capital to Revenue
13.90% 5.02% 1.86% 2.30% -2.86% 11.66% 25.59% 17.57% 18.92% 13.66% 1.23%
Net Working Capital to Revenue
13.90% 5.02% 1.86% 2.30% -2.86% 11.66% 25.59% 17.57% 18.92% 13.66% 1.23%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.10) ($0.12) ($0.10) ($0.07) ($0.08) $0.00 ($0.09) ($0.05) $0.03 ($0.03) ($0.04)
Adjusted Weighted Average Basic Shares Outstanding
54.09M 58.24M 60.50M 61.78M 64.34M 0.00 93.04M 102.41M 95.70M 106.10M 107.73M
Adjusted Diluted Earnings per Share
($0.10) ($0.12) ($0.10) ($0.07) ($0.08) $0.00 ($0.09) ($0.05) $0.03 ($0.03) ($0.04)
Adjusted Weighted Average Diluted Shares Outstanding
54.09M 58.24M 60.50M 61.78M 64.34M 0.00 93.04M 102.41M 95.70M 106.10M 107.73M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
553.91M 555.52M 555.46M 555.85M 557.24M 0.00 584.63M 585.58M 587.42M 588.39M 589.61M
Normalized Net Operating Profit after Tax (NOPAT)
-38 -49 -40 -29 -38 -18 -45 -26 8.68 -17 -22
Normalized NOPAT Margin
-15.55% -23.60% -15.14% -9.43% -9.63% -4.88% -11.55% -5.60% 1.54% -3.54% -4.08%
Pre Tax Income Margin
-21.79% -32.83% -20.77% -12.53% -12.83% -5.25% -14.00% -5.53% 3.60% -3.45% -3.70%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-215.69% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -37.80% -56.94% -58.33% -97.47%
Augmented Payout Ratio
-215.69% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -37.80% -56.94% -58.33% -97.47%

Key Financial Trends

Here are the key financial trends for Symbotic (NASDAQ:SYM) over the past four years, based on quarterly statements through Q2 2025:

  • Strong top-line growth: Q2 2025 revenue of $549.7 million rose 39.7% year-over-year from Q2 2024.
  • Robust operating cash flow: Q2 2025 cash from operations of $269.6 million, driven by working-capital improvements.
  • Healthy liquidity: Cash & equivalents reached $954.9 million in Q2 2025, up from $903.0 million in Q1 2025.
  • Debt-free balance sheet: No long-term debt and net cash position of over $1 billion as of Q2 2025.
  • Positive free cash flow: Q2 2025 FCFF of $38.5 million, turning positive after prior quarters of heavy investment.
  • Deferred revenue backlog remains substantial at roughly $1.1 billion, indicating contracted future work.
  • Noncontrolling interests of $216 million in Q2 2025 represent a material share of equity.
  • Valuation multiples easing: P/Rev of 5.7x and P/B of 57.7x in Q2 2025, down from highs above 7x and 70x earlier in 2025.
  • Continued quarterly losses: Net loss of $21.4 million in Q2 2025 and $18.5 million in Q1 2025.
  • Operating income remains negative: Q2 2025 operating loss of $32.1 million with operating margin of –5.8%.
06/19/25 12:51 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Symbotic's Financials

When does Symbotic's financial year end?

According to the most recent income statement we have on file, Symbotic's fiscal year ends in September. Their fiscal year 2024 ended on September 28, 2024.

How has Symbotic's net income changed over the last 4 years?

Symbotic's net income appears to be on an upward trend, with a most recent value of -$84.67 million in 2024, falling from -$109.52 million in 2020. The previous period was -$207.89 million in 2023. Check out Symbotic's forecast to explore projected trends and price targets.

What is Symbotic's operating income?
Symbotic's total operating income in 2024 was -$116.73 million, based on the following breakdown:
  • Total Gross Profit: $245.67 million
  • Total Operating Expenses: $362.39 million
How has Symbotic's revenue changed over the last 4 years?

Over the last 4 years, Symbotic's total revenue changed from $92.09 million in 2020 to $1.79 billion in 2024, a change of 1,841.9%.

How much debt does Symbotic have?

Symbotic's total liabilities were at $1.19 billion at the end of 2024, a 12.8% increase from 2023, and a 937,511.0% increase since 2020.

How much cash does Symbotic have?

In the past 4 years, Symbotic's cash and equivalents has ranged from $0.00 in 2020 to $727.31 million in 2024, and is currently $727.31 million as of their latest financial filing in 2024.

How has Symbotic's book value per share changed over the last 4 years?

Over the last 4 years, Symbotic's book value per share changed from 0.00 in 2020 to 0.34 in 2024, a change of 168,300.0%.



This page (NASDAQ:SYM) was last updated on 6/19/2025 by MarketBeat.com Staff
From Our Partners